Acurx Pharmaceuticals, Inc. (ACXP) stock
ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.96−0.03 (-2.54%)
Close on Nov 13, 2026Market cap $5.06MP/E –Yield –
Acurx Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Acurx Pharmaceuticals's total assets was $10.34M at Sep 30, 2026. For fiscal 2025 it was $7.69M, up 99.3% from the year before. The highest annual figure on record is $13.25M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.69M | +99.3% |
| FY2024 | Dec 31, 2024 | $3.86M | -50.0% |
| FY2023 | Dec 31, 2023 | $7.71M | -17.8% |
| FY2022 | Dec 31, 2022 | $9.38M | -29.3% |
| FY2021 | Dec 31, 2021 | $13.25M | +311.1% |
| FY2020 | Dec 31, 2020 | $3.22M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.34M | +69.3% |
| Q2 FY2026 | Jun 30, 2026 | $10.98M | +184.7% |
| Q1 FY2026 | Mar 31, 2026 | $9.54M | +45.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.69M | -15.6% |
| Q3 FY2025 | Sep 30, 2025 | $6.11M | -20.8% |
| Q4 FY2024 | Dec 31, 2024 | $3.86M | -58.9% |
| Q2 FY2024 | Jun 30, 2024 | $6.58M | -28.9% |
| Q1 FY2024 | Mar 31, 2024 | $9.11M | -19.5% |
| Q4 FY2023 | Dec 31, 2023 | $7.71M | -41.8% |
| Q4 FY2022 | Dec 31, 2022 | $9.38M | -37.4% |
| Q2 FY2022 | Jun 30, 2022 | $9.26M | -46.9% |
| Q1 FY2022 | Mar 31, 2022 | $11.32M | +251.2% |
| Q4 FY2021 | Dec 31, 2021 | $13.25M | – |
| Q3 FY2021 | Sep 30, 2021 | $14.99M | – |
| Q2 FY2021 | Jun 30, 2021 | $17.44M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.22M | – |
See a number that looks wrong?